Seysara
Drug
Almirall LLC
Total Payments
$1.7M
Transactions
24,336
Doctors
6,981
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $55,466 | 1,827 | 1,116 |
| 2023 | $73,607 | 2,742 | 1,671 |
| 2022 | $367,215 | 5,530 | 2,738 |
| 2021 | $454,453 | 6,919 | 3,431 |
| 2020 | $100,952 | 2,132 | 1,215 |
| 2019 | $650,424 | 5,175 | 2,208 |
| 2018 | $740.09 | 11 | 11 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $563,725 | 200 | 33.1% |
| Unspecified | $555,566 | 149 | 32.6% |
| Food and Beverage | $477,105 | 23,840 | 28.0% |
| Consulting Fee | $88,137 | 40 | 5.2% |
| Travel and Lodging | $18,323 | 107 | 1.1% |
Payments by Type
General
$1.1M
24,187 transactions
Research
$555,566
149 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES) | Almirall LLC | $537,956 | 32 |
| Perioral Dermatitis IIS | Almirall LLC | $17,610 | 1 |
Top Doctors Receiving Payments for Seysara — Page 4
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Dermatology | Norfolk, VA | $3,184 | 22 |
| , MD | Dermatology | Fountain Valley, CA | $3,178 | 17 |
| , MD | Dermatology | New York, NY | $3,109 | 6 |
| , M.D | Dermatology | New Orleans, LA | $3,017 | 8 |
| , M.D | Procedural Dermatology | Cranston, RI | $3,002 | 6 |
| , MD | Dermatology | Bellevue, WA | $2,953 | 6 |
| , D.O | Dermatology | Grand Rapids, MI | $2,846 | 34 |
| , M.D | Specialist | Knoxville, TN | $2,846 | 13 |
| , M D | Procedural Dermatology | Rome, GA | $2,756 | 6 |
| , MD | Dermatology | San Ramon, CA | $2,556 | 2 |
| , MD | Dermatology | Saint Louis, MO | $2,369 | 9 |
| , PA C | Physician Assistant | Gilbert, AZ | $1,757 | 4 |
| , MD | Dermatology | Voorhees, NJ | $1,555 | 120 |
| , FNP | Family | Staten Island, NY | $1,473 | 11 |
| , N.P | Family | Clark, NJ | $1,402 | 10 |
| , PA-C | Dermatology | Middletown, NJ | $1,397 | 108 |
| , D.O | Dermatology | Clark, NJ | $1,321 | 6 |
| , M.D., PH. D | Dermatology | Miami, FL | $1,300 | 1 |
| , M.D | Dermatology | Irvine, CA | $1,222 | 2 |
| , ARNP | Nurse Practitioner | Overland Park, KS | $1,151 | 21 |
| , M.D | Dermatology | Oakbrook Terrace, IL | $1,060 | 48 |
| , P.A | Medical | Rockaway, NJ | $979.16 | 98 |
| , MD, PHD | Dermatology | Hockessin, DE | $862.28 | 4 |
| , PA-C | Physician Assistant | Topeka, KS | $797.67 | 10 |
| , M.D | Dermatology | Overland Park, KS | $769.93 | 43 |
Ad
Manufacturing Companies
- Almirall LLC $1.7M
Product Information
- Type Drug
- Total Payments $1.7M
- Total Doctors 6,981
- Transactions 24,336
About Seysara
Seysara is a drug associated with $1.7M in payments to 6,981 healthcare providers, recorded across 24,336 transactions in the CMS Open Payments database. The primary manufacturer is Almirall LLC.
Payment data is available from 2018 to 2024. In 2024, $55,466 was paid across 1,827 transactions to 1,116 doctors.
The most common payment nature for Seysara is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($563,725, 33.1% of total).
Seysara is associated with 2 research studies, including "Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES)" ($537,956).